BLTE price target raised to $230 by Mizuho
Bullish analyst view, tempered by reliance on a single price target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst view, tempered by reliance on a single price target.
What happened, with direct paths to the underlying reporting
Mizuho raised its target on Belite Bio to $230, about 40% above the posted price of $164.36. This is a single analyst opinion, not a guarantee of upside.
Target: $230
Posted price: $164.36
Analyst firm: Mizuho Securities
Analyst: Graig Suvannavejh
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.